• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Global and China Insulin Industry Report, 2013-2017


News provided by

Reportlinker

Dec 18, 2013, 08:43 ET

Share this article

Share this article


NEW YORK, Dec. 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global and China Insulin Industry Report, 2013-2017
http://www.reportlinker.com/p01929533/Global-and-China-Insulin-Industry-Report-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing market size. In 2012 the global insulin market size reached US$20.8 billion, a year-on-year rise of 12.9%, basically monopolized by Novo Nordisk, Sanofi and Eli Lilly, which altogether accounted for 88.7% of market share.

Being the biggest diabetes power in the world, China currently has 98.4 million patients, accounting for about 25.8% of the world's total. With the maturing of national health insurance system and improvement of economic level, the Chinese insulin drug market size has been on the rise, with the CAGR in 2007-2012 up to 25.4%, well above that of the global insulin market size, and it is expected to maintain a CAGR of at least 15% in the next few years.

Insulin has seen an increasing proportion of Chinese diabetes drug market, from 38.7% in 2007 to 55.6% in 2012. However, due to technical barriers, China's insulin market is mainly occupied by Novo Nordisk, Sanofi and Eli Lilly, of which, Novo Nordisk accounted for 60.3% in 2012. While in recombinant human insulin market segments, the local Chinese enterprise –Tonghua Dongbao Pharmaceutical Co., Ltd. occupied part of the market with approximately 16% share.

Attracted by China's tremendous diabetes drug market, multinational companies like Bayer, United Laboratories as well as the local Wanbang Biopharmaceuticals and Hisun Pharmaceutical are speeding up layout in China's insulin market. Among them, Bayer Schering Pharma has obtained exclusive marketing and distribution rights of Poland's Bioton insulin product "SciLin" in China as early as 2009; the recombinant Lispro Insulin of Wanbang Biopharmaceuticals has also received clinical approval issued by SFDA in September 2013.

Global and China Insulin Industry Report, 2013-2017 mainly covers the followings:
• Development status, supply and demand, competition pattern, R&D for new products, development tendency , etc of global insulin market;
• Relevant policies, supply and demand, import and export, competition pattern, market price, development tendency , etc of Chinese insulin market;
• Operating conditions, insulin business and development forecast, etc of three international insulin giants - Novo Nordisk, Sanofi, Eli Lilly as well as four local companies e.g. Dongbao, Wanbang Biopharmaceuticals.
1. Overview of Insulin
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Insulin Market
2.1 Status Quo
2.2 Market Supply and Demand
2.3 Product R&D
2.4 Competition Pattern
2.5 Trends

3. Development of China Insulin Market
3.1 Status Quo
3.2 Market Supply and Demand
3.3 Import and Export
3.3.1 Insulin and Its Salts
3.3.1.1 Import and Export Value
3.3.1.2 Main Exporting Countries
3.3.1.3 Main Importing Countries
3.3.2 Non-dosed Insulin Containing Drugs
3.3.3 Dosed Insulin Containing Drugs
3.3.4 Insulin Imports of Typical Hospital
3.4 Competition Pattern
3.5 Market Price
3.6 Relevant Policies
3.7 Trends

4. Key Insulin Companies
4.1 Novo Nordisk
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D Expenditure
4.1.6 Insulin Business
4.1.7 Business in China
4.1.8 Development Forecast
4.2 Eli Lilly
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D and Investment

4.2.6 Insulin Business
4.2.7 Business in China
4.2.8 Prospects
4.3 Sanofi
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Insulin Business
4.3.7 Business in China
4.3.8 Prospects
4.4 Dongbao
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin

4.4.5 Clients
4.4.6 R&D and Investment
4.4.7 Insulin Business
4.4.8 Prospects
4.5 Wanbang Biopharmaceuticals
4.5.1 Profile
4.5.2 Operation
4.5.3 Insulin Business
4.6 Gan & Lee
4.6.1 Profile
4.6.2 Operation
4.7 Xinbai Pharmaceutical
4.7.1 Profile
4.7.2 Operation

5. Summary and Forecast
5.1 Comparison of Operations between International Giants and Local Chinese Enterprises
5.2 Industry Forecast
5.2.1 Number of Diabetic Patients in the World
5.2.2 Global Insulin Market Size
5.2.3 Number of Diabetic Patients in China
5.2.4 Chinese Insulin Market Size

Companies Mentioned

Types of Diabetes
Classification of Insulin (by Technical Level / Time)
Recombinant Human Insulin-producing Carriers and Their Characteristics
World's Top 10 Diabetes Drugs by Sales, 2012
Theoretical Global Demand for Insulin API, 2013
R&D Process for Some Insulin Products Worldwide by September 2013
Revenue of the World's Leading Insulin Companies and Their R&D Costs as a Percentage of Revenue, 2012
Insulin Import Value of Typical Hospital in 22 Chinese Cities (by Category), 2008-2012
Maximum Retail Prices of Some Insulin Products in China, 2013
Insulin Drugs Listed in China Health Insurance Directory, 2012
Market Share of Novo Nordisk Insulin (by Country), 2012-2013
Distribution of Novo Nordisk's Subsidiaries in China
Novo Nordisk's Revenue, Net Income and YoY Growth Rate, 2012-2017E
Distribution of Eli Lilly's Cooperative Enterprises (by Product), 2013
Eli Lilly's Revenue, Net Income and YoY Growth Rate, 2012-2017E
Distribution of Sanofi's Main Subsidiaries in China, 2012
Sanofi's Revenue, Net Income and YoY Growth Rate, 2012-2017E
Distribution of Dongbao's Subsidiaries, 2013
Dongbao's Revenue from Top 5 Clients and % of Total Revenue, 2010-2013
Name List and Revenue Contribution of Dongbao's Top 5 Clients, 2012-2013
Dongbao's Revenue, Net Income and YoY Growth Rate, 2012-2017E
Holding Subsidiaries of Wanbang Biopharmaceuticals

Insulin Products of Gan & Lee
Insulin Industry Chain
Number of Diabetic Patients Worldwide, 2007-2013
Number of Patients in the World's Top 10 Diabetes Countries, 2013
Market Size of the World's Top 10 Therapeutic Drugs, 2012
Global Diabetes Drug Market Size and YoY Growth Rate, 2006-2013
Global Diabetes Drug Market Size and Share (by Category), 2012
Global Insulin Market Size and YoY Growth Rate, 2006-2012
Global Per Capita Consumption of Insulin (by Country), 2000 vs. 2013
Global Insulin Pump Market Size, 2012-2017E
Global Insulin Market Share (by Enterprise), 2012
Number of Diabetic Patients in China, 2011-2013
Number and Proportion of Diabetic Patients in China (by Gender), 2013
Number and Proportion of Diabetic Patients in China (by Census Register), 2013
Number and Proportion of Diabetic Patients in China (by Age), 2013
China's Diabetes Drug Market Size and YoY Growth Rate, 2006-2013
China's Insulin Drug Market Size, 2007-2012
Hospital Market Share of Diabetes Treatment in China (by Drug), 2007-2012
Import and Export Value of China's Insulin and Its Salts 2008-2013
Export Value and Proportion of China's Insulin and Its Salts (by Country), 2012
Export Value and Proportion of China's Insulin and Its Salts (by Country), Jan-Sep 2013
Import Value and Proportion of China's Insulin and Its Salts (by Country), 2012
Import Value and Proportion of China's Insulin and Its Salts (by Country), Jan-Sep 2013
Export Value of China's Non-dosed Insulin Containing Drugs, 2010-2013
Export Value of China's Dosed Insulin Containing Drugs and YoY Growth Rate, 2008-2013
Import Value of China's Dosed Insulin Containing Drugs and YoY Growth Rate, 2008-2013
Export Value and Proportion of China's Dosed Insulin Containing Drugs (by Country), 2012
Export Value and Proportion of China's Dosed Insulin Containing Drugs (by Country), Jan-Sep 2013
Import Value of China's Dosed Insulin Containing Drugs (by Country), 2012
Import Value of China's Dosed Insulin Containing Drugs (by Country), Jan-Sep 2013

China's Insulin Market Competition Pattern, 2012
China's Recombinant Human Insulin Market Competition Pattern, 2012
China's Insulin Analog Market Competition Pattern (by Enterprise), 2012
Core Strategy of Novo Nordisk
Novo Nordisk's Revenue and YoY Growth Rate, 2008-2013
Novo Nordisk's Net Income and YoY Growth Rate, 2008-2013
Revenue Breakdown of Novo Nordisk (by Product), 2008-2013
Revenue Breakdown of Novo Nordisk (by Region), 2008-2013
Gross Margin of Novo Nordisk, 2008-2013
R&D Costs and % of Total Revenue of Novo Nordisk, 2008-2013
Modern Insulin Market Segments of Novo Nordisk (by Region), 2012
Insulin Revenue Breakdown of Novo Nordisk (by Product), 2010-2013
Novo Nordisk's Revenue in China and YoY Growth Rate, 2008-2013
Insulin Revenue Breakdown of Novo Nordisk in China (by Product), 2010-2013
Eli Lilly's Revenue and YoY Growth Rate, 2008-2013
Eli Lilly's Net Income and YoY Growth Rate, 2008-2013
Revenue Breakdown of Eli Lilly (by Field), 2010-2013
Revenue Breakdown of Eli Lilly (by Region), 2010-2012
Integrated Gross Margin of Eli Lilly, 2008-2013

R&D Costs and % of Total Revenue of Eli Lilly, 2008-2013
Eli Lilly's Insulin Revenue (by Product) and YoY Growth Rate, 2008-2013
Insulin Revenue Breakdown of Eli Lilly (by Region), 2008-2013
Sanofi's Revenue and YoY Growth Rate, 2008-2013
Sanofi's Net Income and YoY Growth Rate, 2008-2013
Revenue Breakdown of Sanofi (by Product), 2008-2013
Revenue Breakdown of Sanofi (by Region), 2010-2013
Integrated Gross Margin of Sanofi, 2008-2013
R&D Cost of Sanofi (by Product), 2008-2013
Insulin Revenue Breakdown of Sanofi (by Product), 2008-2013
Insulin Revenue Breakdown of Sanofi (by Country or Region), 2011-2013
Sanofi's Revenue in China and YoY Growth Rate, 2009-2013
Dongbao's Revenue and YoY Growth Rate, 2008-2013
Dongbao's Net Income and YoY Growth Rate, 2008-2013
Revenue Breakdown of Dongbao (by Product), 2008-2013
Revenue Breakdown of Dongbao (by Region), 2008-2013
Gross Margin of Dongbao (by Product), 2008-2013
Dongbao's Insulin Revenue and YoY Growth Rate, 2008-2013
Wanbang Biopharmaceuticals' Net Income and YoY Growth Rate, 2008-2013
Revenue and Net Income of Xinbai Pharmaceutical, 2008-2013
Revenue and Net Income of the World's Leading Insulin Companies, 2012
Global Insulin Revenue Breakdown (by Company), 2012
Number of Diabetic Patients in the World, 2007-2017E
Global Insulin Market Size and YoY Growth Rate, 2012-2017E
Number of Diabetic Patients in China, 2011-2017E
Proportion of Insulin Drugs in China's Diabetes Drug Market, 2007-2013
China's Insulin Drug Market Size, 2012-2017E

To order this report: Global and China Insulin Industry Report, 2013-2017
http://www.reportlinker.com/p01929533/Global-and-China-Insulin-Industry-Report-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.